139 related articles for article (PubMed ID: 9163730)
41. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
42. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism.
Giebel LB; Tripathi RK; Strunk KM; Hanifin JM; Jackson CE; King RA; Spritz RA
Am J Hum Genet; 1991 Jun; 48(6):1159-67. PubMed ID: 1903591
[TBL] [Abstract][Full Text] [Related]
43. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y
Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405
[TBL] [Abstract][Full Text] [Related]
44. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.
Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J
Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919
[TBL] [Abstract][Full Text] [Related]
45. [Mutation screening of the TYR and P gene in three patients with oculocutaneous albinism].
Dai C; Li W; Gao B; Li LY; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):373-7. PubMed ID: 18683130
[TBL] [Abstract][Full Text] [Related]
46. Tyrosinase gene mutations in the Chinese Han population with OCA1.
Liu N; Kong XD; Shi HR; Wu QH; Jiang M
Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957
[TBL] [Abstract][Full Text] [Related]
47. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
[TBL] [Abstract][Full Text] [Related]
48. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
49. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
Oetting WS; Fryer JP; King RA
Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
[No Abstract] [Full Text] [Related]
50. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
Oetting WS
Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
[TBL] [Abstract][Full Text] [Related]
51. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
[TBL] [Abstract][Full Text] [Related]
52. Identification of TYR mutations in patients with oculocutaneous albinism.
Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J
Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579
[TBL] [Abstract][Full Text] [Related]
53. Molecular basis of oculocutaneous albinism.
Oetting WS; King RA
J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
[TBL] [Abstract][Full Text] [Related]
54. Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
Liu J; Choy KW; Chan LW; Leung TY; Tam PO; Chiang SW; Lam DS; Pang CP; Lai TY
Clin Exp Ophthalmol; 2010 Jan; 38(1):37-42. PubMed ID: 20447099
[TBL] [Abstract][Full Text] [Related]
55. Single-strand conformation polymorphism analysis of point mutation in a tyrosinase-negative oculocutaneous albinism.
Park KC; Kim KH; Lee YS; Kwon BS
J Inherit Metab Dis; 1994; 17(1):123-6. PubMed ID: 8051921
[No Abstract] [Full Text] [Related]
56. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
57. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
58. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
Oetting WS; King RA
Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
[TBL] [Abstract][Full Text] [Related]
59. Oculocutaneous albinism and analysis of tyrosinase gene in Japanese patients.
Tomita Y; Miyamura Y
Nagoya J Med Sci; 1998 Oct; 61(3-4):97-102. PubMed ID: 9879192
[TBL] [Abstract][Full Text] [Related]
60. Mutation analysis of a Chinese family with oculocutaneous albinism.
Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
